Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.

about

Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.

Item

http://www.wikidata.org/entity/Q54217772

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Repurposing Cytarabine for Tre ...... Latent and Lytic Replications.

@en

Repurposing Cytarabine for Tre ...... Latent and Lytic Replications.

@nl

type

Item

label

Repurposing Cytarabine for Tre ...... Latent and Lytic Replications.

@en

Repurposing Cytarabine for Tre ...... Latent and Lytic Replications.

@nl

prefLabel

Repurposing Cytarabine for Tre ...... Latent and Lytic Replications.

@en

Repurposing Cytarabine for Tre ...... Latent and Lytic Replications.

@nl

P1476

Repurposing Cytarabine for Tre ...... Latent and Lytic Replications

@en

P2093

Chu Lu

http://www.w3.org/2001/XMLSchema#string

Karthik Vasan

http://www.w3.org/2001/XMLSchema#string

Marion Gruffaz

http://www.w3.org/2001/XMLSchema#string

Qing Liu Michael

http://www.w3.org/2001/XMLSchema#string

Shenghua Zhou

http://www.w3.org/2001/XMLSchema#string

Shou-Jiang Gao

http://www.w3.org/2001/XMLSchema#string

Teresa Rushing

http://www.w3.org/2001/XMLSchema#string

P2860

Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis

Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2

Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function

Excessive spinal cord toxicity from intensive central nervous system-directed therapies.

Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation

Molecular biology of KSHV lytic reactivation.

Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV

p53 reactivation kills KSHV lymphomas efficiently in vitro and in vivo: new hope for treating aggressive viral lymphomas.

Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase.

Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.

P31

scholarly article

P356

10.1128/MBIO.00756-18

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jae U Jung

P577

2018-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29739902

http://www.w3.org/2001/XMLSchema#string

P932

5941074

http://www.w3.org/2001/XMLSchema#string